Stage III Skin Melanoma
Information
- Disease name
- Stage III Skin Melanoma
- Disease ID
- Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT02437279 | Active, not recruiting | Phase 1 | Study to Identify the Optimal Adjuvant Combination Scheme of Ipilimumab and Nivolumab in Melanoma Patients | November 24, 2016 | June 2025 |
| NCT00866177 | Completed | Phase 2 | MEK Inhibitor AZD6244 in Treating Patients With Stage III or Stage IV Melanoma | March 2009 | September 2013 |
| NCT00387751 | Completed | Phase 2 | Bevacizumab and Sorafenib in Treating Patients With Unresectable Stage III or Stage IV Malignant Melanoma | August 2006 | January 2010 |
| NCT03112668 | Completed | N/A | Acceptance and Commitment Therapy in Improving Well-Being in Patients With Stage III-IV Cancer and Their Partners | December 6, 2017 | January 25, 2018 |
| NCT03028948 | Completed | N/A | Interactive Tailored Website to Promote Sun Protection and Skin Self-Check Behaviors in Patients With Melanoma | March 13, 2017 | July 12, 2019 |
| NCT03229278 | Completed | Phase 1 | Trigriluzole With Nivolumab and Pembrolizumab in Treating Patients With Metastatic or Unresectable Solid Malignancies or Lymphoma | October 3, 2017 | October 30, 2022 |
| NCT03154190 | Unknown status | N/A | Health Care Coach Support in Reducing Acute Care Use and Cost in Patients With Cancer | August 8, 2017 | August 30, 2022 |